Immunogenicity of Cholera Vaccine in Children With IBD (NCT03998449) | Clinical Trial Compass
CompletedNot Applicable
Immunogenicity of Cholera Vaccine in Children With IBD
Poland80 participantsStarted 2017-08-30
Plain-language summary
Assessment of the immunogenicity and safety of immunization against cholera in children with inflammatory bowel disease.
Who can participate
Age range6 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* diagnosis of Crohn's disease or ulcerative colitis based on standard clinical, endoscopic, histologic and radiographic criteria (Porto criteria),
* no vaccination against cholera in the past,
* written consent of the patient's legal guardians and the patient himself if he/she turns 16 years of age.
Exclusion Criteria:
* serious exacerbation of inflammatory bowel disease defined as Paediatric Ulcerative Colitis Activity Index (PUCAI) \> 65 points for patients with ulcerative colitis or Pediatric Crohn's Disease Activity Index (PCDAI) \> 40 points for patients with Crohn's disease.